10-K - QHSLab, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

QHSLab, Inc. (USAQ) delivered mixed FY2025 results, with robust top-line and gross profit growth offset by lower operating income and a full-year swing to net profitability.

Key Takeaways

1FY2025 revenue rose 26.3% year-over-year to $2.7M, reflecting improved demand for the company’s core product offerings.

2Gross profit grew 33.4% year-over-year to $1.8M, with a 67.3% gross margin driven by favorable product mix shifts and MedScience acquisition synergies.

3Operating income declined 36.2% year-over-year to $131.2K, pressured by higher operating expenses tied to long-term growth investments.

4Net income swung positive to $457.4K for FY2025, compared to a $259.2K net loss reported for the 2024 fiscal year.

5Diluted earnings per share came in at $0.02 for FY2025, reversing the $0.03 per share loss recorded in FY2024.

6Net cash provided by operating activities totaled $178.1K for FY2025, up from $142.4K generated in the prior fiscal year.

7Management expects existing working capital and anticipated cash flows will be adequate to fund operations over the next twelve months.

Key Financial Metrics

EPS

$0.02

166.7%

Revenue

$2.7M

26.3%

Net Income

$457.4K

276.4%

Gross Margin

67.3%

Gross Profit

$1.8M

33.4%

Operating Income

$131.2K

-36.2%

operating margin

4.9%